ALK is a global pharmaceutical company focusing on allergy treatment, prevention and diagnosis. ALK is a world leader in allergy vaccination (immunotherapy) – the only treatment which treats the underlying cause of allergy.
ALK is devoted to improving the quality of life for people with allergies.
ALK has more than 2,000 employees with subsidiaries in several European countries, in the USA and in China. ALK is an independent company, listed on the Danish stock exchange with global headquarters in Hørsholm, Denmark.